M. Kulyk & Associates, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1842370
DECATUR, GA
Position in VRTX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$266,744
+$50,173 QoQ
Shares Held
537
+10.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,283
of 1,735 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026M. Kulyk & Associates, LLC holds $8,296,692 across 2 Biotechnology names. VRTX ranks #2 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,878 | $8,029,948 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
537 | $266,744 |
All Filings in VRTX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $266,744 | 537 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $216,571 | 485 | Shares | Sole | 2026-05-06 | |
| No filing history on record for this holder in this stock. | ||||||